Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 127 of 127 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/30/02
End: 10/31/10
Due: 10/31/11
Phase: N/A
Priority: Normal
Start: 09/30/12
End: 07/31/16
Due: 07/31/17
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With CLL | NCT00072007 | Swiss Group for Clinical Cancer Research | user2@example.com | None | 2002-06-30 | 2010-10-31 | 2011-10-31 | - | - | 2025-07-14 |
| Orteronel Maintenance Therapy in Patients With Metastatic Castration Resistant Prostate Cancer and Non-progressive Disease After First-line Docetaxel Therapy | NCT01707966 | Swiss Group for Clinical Cancer Research | user2@example.com | None | 2012-09-30 | 2016-07-31 | 2017-07-31 | - | - | 2025-07-14 |